Haiyun Shi

No. 95 Yongan Road
Beijing, 100050, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Efficacy, safety, and pharmacokinetics of pumecitinib nasal spray for moderate-to-severe seasonal allergic rhinitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

Efficacy, safety, and pharmacokinetics of pumecitinib nasal spray for moderate-to-severe seasonal allergic rhinitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.

Journal: The Lancet regional health. Western Pacific

Published: July 02, 2026

Clinical applications of gut microbiome for non-invasive diagnosis of colorectal neoplasia.

Clinical applications of gut microbiome for non-invasive diagnosis of colorectal neoplasia.

Journal: Journal of gastroenterology

Published: May 19, 2026

Dual Targeted Therapy for Refractory Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Dual Targeted Therapy for Refractory Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Journal: Journal of evidence-based medicine

Published: December 21, 2025

Impact of Diet and Drugs on Fecal Lachnoclostridium Gene Marker (m3) in Non-Invasive Diagnosis of Colorectal Neoplasia.

Impact of Diet and Drugs on Fecal Lachnoclostridium Gene Marker (m3) in Non-Invasive Diagnosis of Colorectal Neoplasia.

Journal: Journal of gastroenterology and hepatology

Published: September 01, 2025

Discovery and characterization of Christensenella hongkongensis as a novel bacterium in the adenoma-carcinoma progression.

Discovery and characterization of Christensenella hongkongensis as a novel bacterium in the adenoma-carcinoma progression.

Journal: Journal of translational medicine

Published: August 22, 2025

Fecal microbiota composition and function are associated with anxiety and depression in patients with inflammatory bowel disease.

Fecal microbiota composition and function are associated with anxiety and depression in patients with inflammatory bowel disease.

Journal: PloS one

Published: August 06, 2025

Novel fecal microbial biomarkers for noninvasive diagnosis of colorectal cancer and advanced adenomas: A prospective multicenter cohort study.

Novel fecal microbial biomarkers for noninvasive diagnosis of colorectal cancer and advanced adenomas: A prospective multicenter cohort study.

Journal: Chinese medical journal

Published: June 03, 2025

Plasma proteomic markers predict risk for bowel resection in inflammatory bowel disease: a retrospective cohort study.

Plasma proteomic markers predict risk for bowel resection in inflammatory bowel disease: a retrospective cohort study.

Journal: International journal of surgery (London, England)

Published: April 15, 2025

Maslinic acid alleviates ulcerative colitis by inhibiting the colitis-aggravating pathogen Clostridium perfringens and modulating gut microbiota.

Maslinic acid alleviates ulcerative colitis by inhibiting the colitis-aggravating pathogen Clostridium perfringens and modulating gut microbiota.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: March 31, 2025

Identification of Biomarkers for Treatment Escalation of Ulcerative Colitis Based on Untargeted Metabolomics and Machine Learning Algorithms: A Prospective Cohort Study.

Identification of Biomarkers for Treatment Escalation of Ulcerative Colitis Based on Untargeted Metabolomics and Machine Learning Algorithms: A Prospective Cohort Study.

Journal: Clinical and translational gastroenterology

Published: March 29, 2025

LP-003, a novel high-affinity anti-IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled phase 2 clinical trial.

LP-003, a novel high-affinity anti-IgE antibody for inadequately controlled seasonal allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled phase 2 clinical trial.

Journal: Clinical and translational allergy

Published: December 17, 2024

Gut microbiome signatures predict 5-ASA efficacy in ulcerative colitis.

Gut microbiome signatures predict 5-ASA efficacy in ulcerative colitis.

Journal: iScience

Published: December 07, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026